Transcend Therapeutics
Dr. Fargnoli is a Partner at AlleyCorp, where he leads the healthcare investments and incubations. Prior to AlleyCorp, Dr. Fargnoli was a Senior Medical Director at Flatiron Health. He previously worked at J.P. Morgan and Blue Cross & Blue Shield. Board certified in Internal Medicine, Dr. Fargnoli is also a practicing physician. Dr. Fargnoli completed his residency at Harvard’s Brigham and Women’s Hospital. He graduated summa cum laude from the University of Pennsylvania, earning his MD from the University of Pennsylvania School of Medicine and an MBA in Healthcare Management from the Wharton School.
This person is not in the org chart
This person is not in any teams
Transcend Therapeutics
1 followers
Transcend Therapeutics is a clinical-stage, neuroscience-focused company developing next-generation psychoactive medicines for neuropsychiatric disease. Transcend develops medicines that are accessible to a larger percentage of patients in need, specifically the tens of millions of patients who already take psychotropic medication. We have real-world data showing that our lead product provided significant benefit to >85% of patients with PTSD and depression. We have already advanced our lead compound into an approved Phase II study in PTSD, with plans to expand into depression and other indications.